2666 Stock Overview
Offers financing and advisory services in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Genertec Universal Medical Group Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.66 |
| 52 Week High | HK$5.87 |
| 52 Week Low | HK$3.71 |
| Beta | 0.68 |
| 11 Month Change | -5.09% |
| 3 Month Change | 7.13% |
| 1 Year Change | 11.22% |
| 33 Year Change | -13.54% |
| 5 Year Change | -14.65% |
| Change since IPO | -18.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2666 | HK Diversified Financial | HK Market | |
|---|---|---|---|
| 7D | -3.9% | -1.6% | -2.1% |
| 1Y | 11.2% | -2.0% | 9.7% |
Return vs Industry: 2666 exceeded the Hong Kong Diversified Financial industry which returned -2% over the past year.
Return vs Market: 2666 exceeded the Hong Kong Market which returned 9.7% over the past year.
Price Volatility
| 2666 volatility | |
|---|---|
| 2666 Average Weekly Movement | 5.6% |
| Diversified Financial Industry Average Movement | 11.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.1% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 2666 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2666's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 21,521 | Wang Wenbing | www.umcare.cn |
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People’s Republic of China. It operates in two segments, Finance Business and Healthcare Business. The Finance Business segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services.
Genertec Universal Medical Group Company Limited Fundamentals Summary
| 2666 fundamental statistics | |
|---|---|
| Market cap | HK$8.81b |
| Earnings (TTM) | HK$2.22b |
| Revenue (TTM) | HK$14.20b |
4.0x
P/E Ratio0.6x
P/S RatioIs 2666 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2666 income statement (TTM) | |
|---|---|
| Revenue | CN¥13.20b |
| Cost of Revenue | CN¥8.89b |
| Gross Profit | CN¥4.31b |
| Other Expenses | CN¥2.25b |
| Earnings | CN¥2.06b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.09 |
| Gross Margin | 32.66% |
| Net Profit Margin | 15.61% |
| Debt/Equity Ratio | 224.9% |
How did 2666 perform over the long term?
See historical performance and comparison